Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-23-185962
Filing Date
2023-07-12
Accepted
2023-07-12 16:31:11
Documents
18
Period of Report
2023-08-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A d500830ddef14a.htm   iXBRL DEF 14A 684938
6 GRAPHIC g500830g0707050509901.jpg GRAPHIC 6390
7 GRAPHIC g500830g0707050510098.jpg GRAPHIC 3076
8 GRAPHIC g500830g0707050510473.jpg GRAPHIC 27898
9 GRAPHIC g500830g0707050510771.jpg GRAPHIC 25650
10 GRAPHIC g500830g0707050511017.jpg GRAPHIC 25406
  Complete submission text file 0001193125-23-185962.txt   1405488

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cprx-20221231.xsd EX-101.SCH 4064
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cprx-20221231_def.xml EX-101.DEF 3309
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20221231_lab.xml EX-101.LAB 4177
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20221231_pre.xml EX-101.PRE 2511
13 EXTRACTED XBRL INSTANCE DOCUMENT d500830ddef14a_htm.xml XML 97672
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33057 | Film No.: 231085006
SIC: 2834 Pharmaceutical Preparations